STOCK TITAN

BD Board Increases Dividend for 52nd Consecutive Year

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
dividends
Rhea-AI Summary
BD (Becton, Dickinson and Company) (NYSE: BDX) increases quarterly dividend by 4.4% to $0.95 per share, payable on December 29, 2023. The indicated annual dividend rate for fiscal year 2024 is $3.80 per share. BD maintains its membership in the S&P 500 Dividend Aristocrats Index for the 52nd consecutive fiscal year, reflecting confidence in long-term outlook and commitment to create value through BD 2025 strategy.
Positive
  • BD increases its quarterly dividend by 4.4%, indicating confidence in its long-term outlook and commitment to creating value through its BD 2025 strategy.
  • BD maintains its membership in the S&P 500 Dividend Aristocrats Index for the 52nd consecutive fiscal year, showcasing its consistent track record of increasing dividends.
Negative
  • None.

FRANKLIN LAKES, N.J., Nov. 9, 2023 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.95 per common share, an increase of 4.4% from the previous quarter. The dividend will be payable on December 29, 2023 to holders of record on December 8, 2023. The indicated annual dividend rate for fiscal year 2024 is $3.80 per share.

"This is the 52nd consecutive fiscal year in which we have raised our dividend, maintaining BD's membership in the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends for at least 25 consecutive years," said Tom Polen, chairman, CEO and president of BD. "This increase reflects our confidence in our long-term outlook, as well as our ongoing commitment to create value through execution of our BD 2025 strategy and return capital to shareholders."

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.

Contacts:




Media:       

Investors:

Troy Kirkpatrick                                     

Greg Rodetis

VP, Public Relations                             

SVP, Head of Investor Relations

858.617.2361                                         

201.847.6875      

troy.kirkpatrick@bd.com                         

greg.rodetis@bd.com    

 

Cision View original content:https://www.prnewswire.com/news-releases/bd-board-increases-dividend-for-52nd-consecutive-year-301982561.html

SOURCE BD (Becton, Dickinson and Company)

FAQ

What is the quarterly dividend declared by BD (Becton, Dickinson and Company) (NYSE: BDX)?

The quarterly dividend declared by BD is $0.95 per common share, reflecting a 4.4% increase from the previous quarter.

When will the dividend be payable to the shareholders of BD (Becton, Dickinson and Company) (NYSE: BDX)?

The dividend will be payable on December 29, 2023 to holders of record on December 8, 2023.

What is the indicated annual dividend rate for fiscal year 2024 for BD (Becton, Dickinson and Company) (NYSE: BDX)?

The indicated annual dividend rate for fiscal year 2024 is $3.80 per share.

How does BD (Becton, Dickinson and Company) (NYSE: BDX) maintain its membership in the S&P 500 Dividend Aristocrats Index?

BD maintains its membership in the S&P 500 Dividend Aristocrats Index by consistently increasing its dividends for at least 25 consecutive years, reflecting its confidence in its long-term outlook and commitment to creating value through its BD 2025 strategy.

Becton, Dickinson and Co.

NYSE:BDX

BDX Rankings

BDX Latest News

BDX Stock Data

68.54B
288.20M
0.31%
89.29%
1.01%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
FRANKLIN LAKES

About BDX

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.